All In Biotech

Drug Trial Radar · NCT04139395

68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)

Last checked: Nov 20, 2026Latest source record: Aug 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

WithdrawnPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Withdrawn

Enrollment

0

Actual

Start

Jan 15, 2019

Primary completion

Dec 20, 2020

Study completion Dec 20, 2021

Sponsor

Lead sponsor
Carina Mari ApariciAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 25, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase III study to evaluate 68Ga Citrate PET/MRI for detection of origin of fever of unknown origin.

Conditions

  • Fever of Unknown Origin

Interventions

  • 68Ga-Citrate PET/MRIDrug

    Participants will be injected intravenously (IV) with 370 MBq of 68Ga Citrate. 45 -60 minutes after the radiopharmaceutical IV administration, whole body data acquisition at the PET/MRI suite will begin.

  • 67Ga-Citrate SPECTDrug

    67Ga-Citrate will be used as the radiotracer for a regular medical care SPECT scan

  • Positron Emission TomographyDevice

    Imaging with 68Ga-Citrate PET/MRI

  • Magnetic Resonance ImagingDevice

    Imaging with 68Ga-Citrate PET/MRI

  • SPECTDevice

    Imaging with 67Ga-Citrate radiotracer. SPECT scan will be conducted as part of regular medical care.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Uptake detected by investigational imaging agentTime frame: Up to 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stanford University

    Palo Alto, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.